Experience the "Xiamen Day" at Expo 2025 Osaka and Embark on a New Journey of Diverse Exchange
OSAKA, Japan, May 20, 2025 /PRNewswire/ -- At the end of this month, the "Xiamen Day" will be launched at Expo 2025 Osaka, Japan. Individuals from all sectors are welcomed to this grand celebration. "Xiamen Day" will encompass a diverse range of...
HTX Launches Multi-Assets Collateral Mode for USDT-Margined Futures, Empowering Traders With Enhanced Capital Efficiency
SINGAPORE, May 20, 2025 /PRNewswire/ -- HTX, a leading global cryptocurrency exchange has rolled out a major product upgrade with the official launch of the Multi-Assets Collateral Mode for USDT-margined futures, now available to all users. This new...
Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC
SHANGHAI, May 20, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative therapies in immunology and oncology, today announced that the first patient has been successfully dosed in...
MiTAC Computing Democratizes AI at COMPUTEX 2025
TAIPEI, May 20, 2025 /PRNewswire/ -- At COMPUTEX 2025, MiTAC Computing Technology Corporation, a leading server platform designer and manufacturer and a subsidiary of MiTAC Holdings Corporation (TSE:3706), drives innovation in AI, High-Performance...
Storage Meets AI at COMPUTEX 2025: Lexar Introduces Innovative Product Lines
TAIPEI, May 20, 2025 /PRNewswire/ -- Lexar, a leading global brand in storage solutions, is showcasing its innovations at Computex 2025, held from May 20 to 23 at the Taipei Nangang Exhibition Center. Under the theme "Storage Meets AI," Lexar is...
ZKH Group Limited Announces First Quarter 2025 Unaudited Financial Results
SHANGHAI, May 20, 2025 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform in China, today announced its unaudited financial results for the first...
Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
- The combination study is designed to evaluate the safety and preliminary efficacy of a single-dose of ultra-long-acting subcutaneously administered ASC47 in combination with four doses of semaglutide (0.5 mg, once-weekly) in participants with...
BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025
BARCELONA, Spain, May 20, 2025 /PRNewswire/ -- BIOFLAG CO.,LTD.(Bioflag), a leading probiotic enterprise located in China, proudly unveiled its scientifically validated functional probiotic solutions at Vitafoods Europe 2025, drawing high attention...